Matthias Egger
@MatthiasEgger11
Followers
86
Following
249
Media
1
Statuses
40
Research fellow at Medical University Graz, Austria Interested in Translational Mycology
Graz
Joined February 2022
Pneumocystis Treatment, tmp-smx and alternative drugs https://t.co/7oiDytruNF
clinicalmicrobiologyandinfection.org
Pneumocystis jirovecii pneumonia (PCP) is a serious opportunistic infection in people living with HIV (PWH) who have low CD4 counts. Despite its side effects, trimethoprim–sulfamethoxazole (TMP-SMX)...
0
5
13
🔥📰Review on "Climate Change and Medical Mycology" Congrats to @SarahSedik and @MatthiasEgger11 for great figures, tables and content! 🙏to the editors for the invite Full access here https://t.co/4gxOCQDlr1
0
34
53
Great #YECMM networking event last night under a giant 🍄 ! Thanks to all YECMM members who joined. To be renewed at #ESCMIDGlobal next year ! @RosanneSprute @sarah_delliere @MatthiasEgger11 and ⬇️
3
12
50
Our #ECCMID2024 get-together will take place at 🚩Alice Secret Garden https://t.co/deuIYh6fDH 📋RSVP still online https://t.co/RRsElEATPj See you 🍄
1
12
16
Are you under 40 years of age and want to be part of an international program in your early career in mycology? ➡️Join @YoungECMM and enjoy its benefits 🔗Apllication form https://t.co/F7icd15A5L 🍄Further info on https://t.co/eHut9TOOPf Looking forward to connect and thrive 💫
ecmm.info
Welcome to the Young ECMM programme Become the face of the next generation in medical mycology, become a Young ECMM fellow. Be part of the international programme in your early career in mycology to...
0
16
30
Hey young Mycologists 👋 This is a reminder to our event during #ECCMID2024 on Sunday 28/04, 7:30pm Please 📝RSVP using the link below! Details on the location will be announced next week 📍 Looking forward to meet and connect in #Barcelona
YECMM is planning a 🍄 get-together during #ECCMID2024 ! Are you a young clinician/scientist interested in mycology ? Join us on Sunday 28/04. 👉 RSVP : https://t.co/RRsElEATPj [Form to register will be sent shortly to those who RSVP and are interested to join YECMM]
1
7
11
Fantastic 🆕️🔥Narrative Review @CMIJournal by 🌟s @krielisa_ @martinhoenigl New treatment options for critically important WHO fungal priority pathogens ⭕️Aspergillus fumigatus ⭕️Cryptococcus neoformans ⭕️Candida albicans ⭕️Candida auris #IDXposts
https://t.co/4K4iITosGY
4
107
220
YECMM is planning a 🍄 get-together during #ECCMID2024 ! Are you a young clinician/scientist interested in mycology ? Join us on Sunday 28/04. 👉 RSVP : https://t.co/RRsElEATPj [Form to register will be sent shortly to those who RSVP and are interested to join YECMM]
0
14
32
Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices? @krielisa_ and Johannes Boyer https://t.co/JoxFDKU9uq
tandfonline.com
Despite advancements, invasive fungal infections (IFI) still carry high mortality rates, often exceeding 30%. The challenges in diagnosis, coupled with limited effective antifungal options, make ma...
0
27
71
🔥🔥 Public consultation #Global #Candida #Guideline NOW ➡️ https://t.co/VK1cqH6qZd 🙏🙏🙏@eurconfmedmycol @ISHAM_Mycology @neil_gow @martinhoenigl @ProfMBassetti @OKurzai @DrLuisO @RosanneSprute @SalmantonGarcia @BirgitWillinger Please RT📢need your input📢
2
39
45
Super proud to see our latest paper out in @LancetMicrobe ! A short thread 🧵 (1/n)
thelancet.com
Qualitative and quantitative disturbances in monocyte, macrophage, B-cell, and T-cell populations could predispose patients with severe COVID-19 to develop CAPA. Hybrid neutrophils form a specialised...
2
20
44
CAPA in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis Posaconazole ⬇️CAPA incidence rate at our center. Future trials will focus on a more nuanced, risk-factors based prophylactic approach. @martinhoenigl @reisinger_alex
https://t.co/CkAqVFFlfC
0
7
20
Risk of COVID-19-associated pulmonary aspergillosis: time for a nuanced approach to antifungal prophylaxis? https://t.co/9v9DFF4Ek4 Learning about the individual risk for #CAPA development will allow for a more individualized #COVID19 management @martinhoenigl @LancetRespirMed
1
14
30
🔥🗞️📰 Social determinants of health as drivers of fungal disease. @eClinicalMed Led by @JeffreyJenks5 with @jprattes @RosanneSprute @matteosciart @MatthiasEgger11 @HatimSati @CarlosdelRio7 @CornelyOliver @GRThompsonMD among others. https://t.co/WbpZYV6Kjy
1
41
95
Heading home from a wonderful @TIMM_cc in sunny #Athens 🌺Was a successful start for the @YoungECMM with two YECMM sessions and a great party 🤩 Looking forward to the next two years as YECMM board member together with @sarah_delliere and @MatthiasEgger11 @seidel_dani @jprattes☀️
1
9
43
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management | Clinical Microbiology Reviews @ASMicrobiology under lead of @GRThompsonMD with great team including @MatthiasEgger11 @GermHunterMD @jobadd & many more https://t.co/fQJ40Z8WKv
journals.asm.org
Fungal endocarditis accounts for 1% to 3% of all infective endocarditis cases, is associated with high morbidity and mortality (>70%), and presents numerous challenges during clinical care. Candida...
1
56
124
Very comprehensive review on when and how to do #antifungal prophylaxis/pre-emptive therapy in pts with different baseline characteristics. Led by @RosanneSprute @JannikStemler. @CornelyOliver @JuliaNacov @matteosciart #DionysiosNeofytos #IlanaReinhold
https://t.co/dIyY4FJSMc
0
18
37
Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap. @LancetMicrobe
@Amir36520680 @farnazDan66 @toni_gabaldon @cnobile1 @jnalmeidajr Figures by @MatthiasEgger11
https://t.co/boBfyNwHoh
2
38
80
👉Fruitful collaboration about current and future treatment options for #invasiveaspergillosis in @mycopathologia ⌛️💉💊🍄 Thanks to @s_feys @martinhoenigl Read here: https://t.co/2xu5uaKTYP
1
19
47